Advertisement

Persisting Ductus Arteriosus and Intraventricular Hemorrhage

  • Rolf F. Maier

Keywords

Patent Ductus Arteriosus Superior Vena Cava Severe Preeclampsia Persist Ductus Arteriosus Prenatal Steroid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amorim MM, Santos LC, Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999; 180: 1283–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. New Engl J Med 1989; 320: 1511–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; CD003745.Google Scholar
  4. 4.
    Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child 1996; 75: F183–6.CrossRefGoogle Scholar
  5. 5.
    Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002; CD000174.Google Scholar
  6. 6.
    Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2003; CD003481.Google Scholar
  7. 7.
    Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2003; CD004213.Google Scholar
  8. 8.
    Sheth RD. Trends in incidence and severity of intraventricular hemorrhage. J Child Neurol 1998; 13: 261–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Siassi B, Blanco C, Cabal LA, Coran AG. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: A prospective analysis of 150 consecutively born infants. Pediatrics 1976; 57: 347–51.PubMedGoogle Scholar
  10. 10.
    Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000; CD000511.Google Scholar
  11. 11.
    Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/ intraventricular hemorrhage in premature infants. Pediatrics 2003; 112: 33–39.CrossRefPubMedGoogle Scholar
  12. 12.
    Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preteme infants. Arch Dis Child Fetal Neonatal Ed 2000; 82: F188–F194.PubMedGoogle Scholar
  13. 13.
    Su PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 2003; 45: 665–70.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • Rolf F. Maier
    • 1
  1. 1.Department of Neonatology and Pediatric NeurologyKlinikum der Philipps-Universität MarburgMarburg

Personalised recommendations